• Company
• Pulmican·Pulmicort prescriptions surge in asthma Tx mkt
• by Chon, Seung-Hyun Aug 5, 2024 07:50am

• Company
• Bosulif, 2nd-generation leukemia drug available in Big 5
• by Eo, Yun-Ho Aug 5, 2024 07:50am

• Company
• Fresenius Kabi launches 2 Ntense amino acid solutions
• by Eo, Yun-Ho Aug 2, 2024 05:52am

• Company
• GC·Hanmi submit IND apl. for new 'Fabry disease' drug
• by Son, Hyung-Min Aug 2, 2024 05:52am

• Company
• Next Biomedical seeks IPO…knocks on global GI mkt
• by Hwang, Byung-woo Aug 2, 2024 05:52am

• Company
• Mounjaro bids into Korea's obesity treatment market
• by Hwang, Byung-woo Aug 2, 2024 05:51am

• Company
• New oHCM drug 'Camzyos' is under review for reimb list
• by Eo, Yun-Ho Aug 2, 2024 05:51am

• Company
• VUNO knocks on the U.S. market to generate operating profit
• by Hwang, Byung-woo Aug 1, 2024 05:48am

• Company
• Celltrion’s Steqeyma approved in CAN…targets Stelara mkt
• by Hwang, Byung-woo Aug 1, 2024 05:48am

• Company
• Will the cardiomyopathy drug Vyndamax be reimb this time?
• by Eo, Yun-Ho Aug 1, 2024 05:48am